157 related articles for article (PubMed ID: 17387386)
1. Differential expression of runx2 and Indian hedgehog in cartilaginous tumors.
Park HR; Park YK
Pathol Oncol Res; 2007; 13(1):32-7. PubMed ID: 17387386
[TBL] [Abstract][Full Text] [Related]
2. Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas.
Rozeman LB; Hameetman L; Cleton-Jansen AM; Taminiau AH; Hogendoorn PC; Bovée JV
J Pathol; 2005 Mar; 205(4):476-82. PubMed ID: 15685701
[TBL] [Abstract][Full Text] [Related]
3. The MAPK-AP-1/-Runx2 signalling axes are implicated in chondrosarcoma pathobiology either independently or via up-regulation of VEGF.
Papachristou DJ; Papachristou GI; Papaefthimiou OA; Agnantis NJ; Basdra EK; Papavassiliou AG
Histopathology; 2005 Dec; 47(6):565-74. PubMed ID: 16324193
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of estrogen receptors in chondrosarcomas and enchondromas.
Grifone TJ; Haupt HM; Podolski V; Brooks JJ
Int J Surg Pathol; 2008 Jan; 16(1):31-7. PubMed ID: 18203781
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of A disintegrin and metalloproteinase 28 is correlated with high histologic grade in conventional chondrosarcoma.
Matsuura S; Oda Y; Matono H; Izumi T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2010 Mar; 41(3):343-51. PubMed ID: 19896699
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of matrilin-3 not only in osteoarthritic articular cartilage but also in cartilage-forming tumors, and down-regulation of SOX9 via epidermal growth factor domain 1-dependent signaling.
Vincourt JB; Vignaud JM; Lionneton F; Sirveaux F; Kawaki H; Marchal S; Lomazzi S; Plénat F; Guillemin F; Netter P; Takigawa M; Mainard D; Magdalou J
Arthritis Rheum; 2008 Sep; 58(9):2798-808. PubMed ID: 18759284
[TBL] [Abstract][Full Text] [Related]
7. Expression of insulin-like growth factor II mRNA binding protein 3 (IMP3) in enchondroma and chondrosarcoma.
Shooshtarizadeh T; Nazeri A; Zare-Mirzaie A; Movahedinia S
Pathol Res Pract; 2016 Apr; 212(4):335-9. PubMed ID: 26948096
[TBL] [Abstract][Full Text] [Related]
8. Type X collagen expression and hypertrophic differentiation in chondrogenic neoplasias.
Aigner T; Frischholz S; Dertinger S; Beier F; Girkontaité I; von der Mark K
Histochem Cell Biol; 1997 Jun; 107(6):435-40. PubMed ID: 9243276
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor-alpha receptor expression supports the growth of conventional chondrosarcoma and is associated with adverse outcome.
Sulzbacher I; Birner P; Trieb K; Mühlbauer M; Lang S; Chott A
Am J Surg Pathol; 2001 Dec; 25(12):1520-7. PubMed ID: 11717542
[TBL] [Abstract][Full Text] [Related]
10. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone.
Hasegawa T; Seki K; Yang P; Hirose T; Hizawa K; Wada T; Wakabayashi J
Hum Pathol; 1995 Aug; 26(8):838-45. PubMed ID: 7543439
[TBL] [Abstract][Full Text] [Related]
11. Ihh and Runx2/Runx3 signaling interact to coordinate early chondrogenesis: a mouse model.
Kim EJ; Cho SW; Shin JO; Lee MJ; Kim KS; Jung HS
PLoS One; 2013; 8(2):e55296. PubMed ID: 23383321
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible factor 1-alpha and vascular endothelial growth factor in cartilage tumors.
Kouvaras E; Christoni Z; Siasios I; Malizos K; Koukoulis GK; Ioannou M
Biotech Histochem; 2019 May; 94(4):283-289. PubMed ID: 30605014
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression.
van Beerendonk HM; Rozeman LB; Taminiau AH; Sciot R; Bovée JV; Cleton-Jansen AM; Hogendoorn PC
J Pathol; 2004 Mar; 202(3):359-66. PubMed ID: 14991902
[TBL] [Abstract][Full Text] [Related]
14. Groucho homologue Grg5 interacts with the transcription factor Runx2-Cbfa1 and modulates its activity during postnatal growth in mice.
Wang W; Wang YG; Reginato AM; Glotzer DJ; Fukai N; Plotkina S; Karsenty G; Olsen BR
Dev Biol; 2004 Jun; 270(2):364-81. PubMed ID: 15183720
[TBL] [Abstract][Full Text] [Related]
15. Constitutive hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferation.
Tiet TD; Hopyan S; Nadesan P; Gokgoz N; Poon R; Lin AC; Yan T; Andrulis IL; Alman BA; Wunder JS
Am J Pathol; 2006 Jan; 168(1):321-30. PubMed ID: 16400033
[TBL] [Abstract][Full Text] [Related]
16. Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma.
Takeuchi A; Yamamoto Y; Tsuneyama K; Cheng C; Yonekura H; Watanabe T; Shimizu K; Tomita K; Yamamoto H; Tsuchiya H
Cancer; 2007 Jun; 109(12):2532-40. PubMed ID: 17497647
[TBL] [Abstract][Full Text] [Related]
17. Signaling networks in RUNX2-dependent bone development.
Komori T
J Cell Biochem; 2011 Mar; 112(3):750-5. PubMed ID: 21328448
[TBL] [Abstract][Full Text] [Related]
18. Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells.
Pratap J; Wixted JJ; Gaur T; Zaidi SK; Dobson J; Gokul KD; Hussain S; van Wijnen AJ; Stein JL; Stein GS; Lian JB
Cancer Res; 2008 Oct; 68(19):7795-802. PubMed ID: 18829534
[TBL] [Abstract][Full Text] [Related]
19. Expression of Amphiregulin in Enchondromas and Central Chondrosarcomas.
Losada DM; Ribeiro ALDC; Cintra FF; Mendonça GRA; Etchebehere M; Amstalden EMI
Clinics (Sao Paulo); 2021; 76():e2914. PubMed ID: 34468540
[TBL] [Abstract][Full Text] [Related]
20. C-propeptides of procollagens I alpha 1 and II that differentially accumulate in enchondromas versus chondrosarcomas regulate tumor cell survival and migration.
Vincourt JB; Etienne S; Cottet J; Delaunay C; Malanda CB; Lionneton F; Sirveaux F; Netter P; Plénat F; Mainard D; Vignaud JM; Magdalou J
Cancer Res; 2010 Jun; 70(11):4739-48. PubMed ID: 20460531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
